SAN FRANCISCO — In patients with suspected myocardial infarction (MI) with nonobstructive coronary lesions, an intensive approach to diagnosis and subsequent tailored treatment based on the underlying ...
SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results